Drug Trial Radar · NCT05514054
A Study of Imlunestrant Versus Standard Endocrine Therapy in Participants With Early Breast Cancer
Last checked: Nov 19, 2026Latest source record: Apr 2, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
8,000
Planned (sponsor's estimate)
Start
Oct 4, 2022
Primary completion
Oct 2027
Study completion Mar 2032
Sponsor
- Lead sponsor
- Eli Lilly and CompanyEli Lilly (LLY)
- Sponsor type
- Industry
- First posted
- Aug 24, 2022
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The main purpose of this study is to measure how well imlunestrant works compared to standard hormone therapy in participants with early breast cancer that is estrogen receptor positive (ER+) and human epidermal receptor 2 negative (HER2-). Participants must have already taken endocrine therapy for two to five years and must have a higher-than-average risk for their cancer to return. Study participation could last up to 10 years.
Conditions
- Breast Neoplasms
Interventions
ImlunestrantDrug
Administered orally.
TamoxifenDrug
Administered per local approved label.
AnastrozoleDrug
Administered per local approved label.
LetrozoleDrug
Administered per local approved label.
ExemestaneDrug
Administered per local approved label.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Invasive Disease-Free Survival (IDFS)Time frame: Randomization to recurrence or death from any cause (up to 10 years)
Locations
672 sites in 31 countries. Site status is shown where the registry gives one.
USO - Southern Cancer Center
Daphne, Alabama
Clearview Cancer Institute
Huntsville, Alabama
Infirmary Cancer Care
Mobile, Alabama
Banner MD Anderson Cancer Center
Gilbert, Arizona
USO - Arizona Oncology Associates - HAL
Glendale, Arizona
St. Joseph's Hospital and Medical Center
Phoenix, Arizona
Mayo Clinic in Arizona - Phoenix
Phoenix, Arizona
TMC HealthCare
Tucson, Arizona
The University of Arizona Cancer Center - North Campus
Tucson, Arizona
Highlands Oncology Group
Springdale, Arkansas
UCSF - John Muir Health Cancer Center Berkeley
Berkeley, California
Washington Health
Fremont, California
Chao Family Comprehensive Cancer Center and Ambulatory Care (CIACC) - Irvine
Irvine, California
Loma Linda University Cancer Center
Loma Linda, California
Pacific Cancer Care
Monterey, California
St. Joseph Hospital
Orange, California
University of California, Irvine (UCI) Health - UC Irvine Medical Center
Orange, California
University of California Davis (UC Davis) Comprehensive Cancer Center
Sacramento, California
Kaiser Permanente San Diego Mission Road
San Diego, California
Zuckerberg San Francisco General Hospital and Trauma Center
San Francisco, California
UCSF Medical Center at Mission Bay
San Francisco, California
Saint Joseph's Medical Center
Stockton, California
Anschutz Cancer Pavilion
Aurora, Colorado
UCHealth Memorial Hospital
Colorado Springs, Colorado
UCHealth Harmony
Fort Collins, Colorado
Banner MD Anderson Cancer Center at North Colorado Medical Center
Greeley, Colorado
USO - Rocky Mountain Cancer Centers
Lakewood, Colorado
Banner MD Anderson Cancer Center at McKee Medical Center
Loveland, Colorado
Yale-New Haven Hospital
New Haven, Connecticut
Georgetown University Medical Center
Washington D.C., District of Columbia
MedStar Washington Hospital Center
Washington D.C., District of Columbia
AdventHealth Altamonte Springs
Altamonte Springs, Florida
Memorial Regional Hospital
Hollywood, Florida
Millennium Oncology Research Clinic
Hollywood, Florida
Mayo Clinic in Florida
Jacksonville, Florida
Miami Cancer Institute at Baptist Health, Inc.
Miami, Florida
USO - Cancer Care Centers of Brevard
Palm Bay, Florida
USO - Woodlands Medical Specialists
Pensacola, Florida
Miami Cancer Institute - Plantation
Plantation, Florida
Tampa General Hospital
Tampa, Florida
Showing 40 of 672 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.